Tavolimab - anti-OX40 monoclonal antibody MEDI0562
According to the NCI website, Tavolimab is an agonistic, humanized monoclonal antibody against receptor OX40 (CD134), with potential immunostimulatory activity. Check for active clinical trials using this agent. (NCI Thesaurus)
Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute